ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2025

Strategic behavior and entry deterrence by branded drug firms: the case of authorized generic drugs.

Lu Yao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.